First-in-human results of terbium-161 [161Tb]Tb-PSMA-I&T dual beta–Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 study
- Journal:
- The Lancet Oncology
- Published:
- Affiliations:
- 8
- Authors:
- 30
| Institutions | Authors | Share |
|---|---|---|
| Peter MacCallum Cancer Centre (Peter Mac), Australia | 0.77 | |
| The University of Melbourne (UniMelb), Australia | 0.23 |